BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27801742)

  • 21. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT.
    Okamura K; Yonemoto Y; Arisaka Y; Takeuchi K; Kobayashi T; Oriuchi N; Tsushima Y; Takagishi K
    Rheumatology (Oxford); 2012 Aug; 51(8):1484-91. PubMed ID: 22513145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-FDG PET/CT in Bladder Cancer.
    Tagliabue L; Russo G; Lucignani G
    Clin Nucl Med; 2016 Dec; 41(12):e522-e524. PubMed ID: 27824327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18F-FDG PET/CT Findings in a Patient With a Proliferating Trichilemmal Cyst.
    Leyendecker P; de Cambourg G; Mahé A; Imperiale A; Blondet C
    Clin Nucl Med; 2015 Jul; 40(7):598-9. PubMed ID: 25706794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse-Type Tenosynovial Giant Cell Tumor of the Shoulder Evaluated by FDG PET/CT.
    Tang K; Zheng X; Lin J; Wang L
    Clin Nucl Med; 2019 Apr; 44(4):310-312. PubMed ID: 30624274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
    Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S
    Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging.
    Kaneuchi Y; Hakozaki M; Yamada H; Hasegawa O; Tajino T; Konno S
    Hell J Nucl Med; 2016; 19(1):46-8. PubMed ID: 26929940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac amyloidosis incidentally detected by 18F-FDG PET/CT.
    Gazzilli M; Bertoli M; Albano D; Durmo R; Cerudelli E; Bertagna F; Giubbini R
    J Nucl Cardiol; 2020 Dec; 27(6):2429-2431. PubMed ID: 31907857
    [No Abstract]   [Full Text] [Related]  

  • 28. 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
    Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Talbot JN; Garderet L
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1995-2004. PubMed ID: 27121691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences of articular and extra-articular involvement in polymyalgia rheumatica: A comparison by whole-body FDG-PET/CT.
    Kaneko K; Suematsu E; Miyamura T; Ishioka H
    Mod Rheumatol; 2020 Mar; 30(2):358-364. PubMed ID: 30843747
    [No Abstract]   [Full Text] [Related]  

  • 30. Bronchiectasis as a Cause of Elevated CA-19-9 Demonstrated on 18F-FDG PET/CT.
    Mikhail P; Le K; Bui C; Mansberg R
    Clin Nucl Med; 2018 Mar; 43(3):207-208. PubMed ID: 29293134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary amyloidosis presenting as unusual cutaneous nodules diagnosed by 18F-FDG PET/CT aided biopsy: a case report.
    Wang Y; Song Z; Zhang S; Yu X; Cui Y; Zhang Z
    QJM; 2023 Mar; 116(3):237-238. PubMed ID: 36218976
    [No Abstract]   [Full Text] [Related]  

  • 32. Extra-articular knee lesion with high fluorodeoxyglucose-uptake on positron emission tomography.
    Paul JC; Unnanuntana A; Goldsmith SJ; Lane JM
    Bull Hosp Jt Dis (2013); 2013; 71(2):170-4. PubMed ID: 24032621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review.
    Mekinian A; Jaccard A; Soussan M; Launay D; Berthier S; Federici L; Lefèvre G; Valeyre D; Dhote R; Fain O;
    Amyloid; 2012 Jun; 19(2):94-8. PubMed ID: 22587492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicentric Reticulohistiocytosis Mimicking Malignancy on 18F-FDG PET/CT.
    Hotta M; Minamimoto R; Suzuki D; Takahashi A
    Clin Nucl Med; 2017 Jul; 42(7):567-568. PubMed ID: 28368895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Rehak Z; Sprlakova-Pukova A; Kazda T; Fojtik Z; Vargova L; Nemec P
    Br J Radiol; 2017 Aug; 90(1076):20170198. PubMed ID: 28508663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDG-PET/CT in the evaluation of anal carcinoma.
    Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymic Small Cell Neuroendocrine Carcinoma Displayed on 18F-FDG PET/CT Imaging.
    Jiang L; Li Y; Luan L; Zhang Y; Shi H
    Clin Nucl Med; 2016 May; 41(5):382-4. PubMed ID: 26673232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometriosis Mimicking an Advanced Malignant Tumor.
    Wang T; Xing Y; Zhao J
    Clin Nucl Med; 2016 Aug; 41(8):648-9. PubMed ID: 27187736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bibliography.
    Man Ther; 2002 Nov; 7(4):229-33. PubMed ID: 12481792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.